Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation

Endometrial cancerOncogenic pathway alterationsPI3K-AKT pathwayWnt signaling pathwayMicrosatellite-instabilityP53 mutation